ISLMF (InSilico Medicine Cayman TopCo) Interest Coverage: 0 (At Loss) (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISLMF InSilico Medicine Cayman TopCo ISLMF
13 GF Score
Price $6.11
! 3 Warning Signs
View Full Analysis

What is InSilico Medicine Cayman TopCo Interest Coverage?

InSilico Medicine Cayman TopCo ISLMF -1.77% 13 Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus rates ISLMF with a GF Score™ of 13/100. The stock has 3 warning signs investors should review. Among 1,727 Software companies, InSilico Medicine Cayman TopCo ranks worse than 57903.82% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. InSilico Medicine Cayman TopCo's Operating Income for the three months ended in Dec. 2025 was $-39.26 Mil. InSilico Medicine Cayman TopCo's Interest Expense for the three months ended in Dec. 2025 was $-0.11 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for InSilico Medicine Cayman TopCo's Interest Coverage or its related term are showing as below:


ISLMF's Interest Coverage is not ranked *
in the Software industry.
Industry Median: 26.06
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


InSilico Medicine Cayman TopCo  (OTCPK:ISLMF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


InSilico Medicine Cayman TopCo Interest Coverage Related Terms


InSilico Medicine Cayman TopCo Interest Coverage Historical Data

* Premium members only.

The historical data trend for InSilico Medicine Cayman TopCo's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

InSilico Medicine Cayman TopCo Interest Coverage Chart

InSilico Medicine Cayman TopCo Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Interest Coverage
0.00 0.00 0.00 0.00

InSilico Medicine Cayman TopCo Quarterly Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Coverage Get a 7-Day Free Trial N/A 143.59 0.00 0.00 0.00

ISLMF vs : Interest Coverage Comparison

For the Software - Infrastructure subindustry, InSilico Medicine Cayman TopCo's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InSilico Medicine Cayman TopCo Interest Coverage vs Software Industry

For the Software industry and Technology sector, InSilico Medicine Cayman TopCo's Interest Coverage distribution charts can be found below:

* The bar in red indicates where InSilico Medicine Cayman TopCo's Interest Coverage falls into.


ISLMF
13GF Score
InSilico Medicine Cayman TopCo ISLMF
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InSilico Medicine Cayman TopCo Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

InSilico Medicine Cayman TopCo's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, InSilico Medicine Cayman TopCo's Interest Expense was $-0.21 Mil. Its Operating Income was $-62.05 Mil. And its Long-Term Debt & Capital Lease Obligation was $4.06 Mil.

InSilico Medicine Cayman TopCo did not have earnings to cover the interest expense.

InSilico Medicine Cayman TopCo's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Here, for the three months ended in Dec. 2025, InSilico Medicine Cayman TopCo's Interest Expense was $-0.11 Mil. Its Operating Income was $-39.26 Mil. And its Long-Term Debt & Capital Lease Obligation was $4.06 Mil.

InSilico Medicine Cayman TopCo did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
InSilico Medicine Cayman TopCo (ISLMF) has a Interest Coverage of 0 (At Loss) as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on InSilico Medicine Cayman TopCo and its competitors. According to the industry distribution chart, InSilico Medicine Cayman TopCo ranks #999999 out of 1727 companies in the Software industry.
Is InSilico Medicine Cayman TopCo's Interest Coverage too high?
InSilico Medicine Cayman TopCo's current Interest Coverage is 0 (At Loss). Based on the distribution chart, InSilico Medicine Cayman TopCo ranks #999999 out of 1727 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, InSilico Medicine Cayman TopCo has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does InSilico Medicine Cayman TopCo's Interest Coverage compare to ?
According to the Software industry distribution chart, InSilico Medicine Cayman TopCo ranks #999999 out of 1727 companies for Interest Coverage. This places InSilico Medicine Cayman TopCo in the lower half of its industry. The industry median Interest Coverage is 26.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Software company?
The median Interest Coverage among Software companies is 26.06, based on 1,727 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on InSilico Medicine Cayman TopCo and its competitors. For the Software industry, the median Interest Coverage is 26.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InSilico Medicine Cayman TopCo's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InSilico Medicine Cayman TopCo stock overvalued right now?
InSilico Medicine Cayman TopCo (ISLMF) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). InSilico Medicine Cayman TopCo's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For InSilico Medicine Cayman TopCo (ISLMF), the current Interest Coverage is 0 (At Loss) as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

InSilico Medicine Cayman TopCo Business Description

Comparable Companies
Other Exchanges 03696:Hong KongO15:Germany
Address Hong Kong Science Park, Unit 310, 3rd Floor, Building 8W, Phase 2, Pak Shek Kok, New Territories, Hong Kong, HKG
InSilico Medicine Cayman TopCo is engaged in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. It has generated multiple clinical-stage or IND-enabling assets using Pharma.AI, an AI-enabled platform that supports drug discovery and development activities. The company operates under a project-based business model, deriving revenue from out-licensing and collaboration arrangements. Geographically, the company generates revenue from multiple countries, with the majority of the revenue coming from United States.
13GF Score

Get the complete analysis for ISLMF

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.11
Price